Skip to content

Indivior

US · INDV #2252 by market cap Listed 1970
0.00 +0.91 +2.57%
Snapshot may be outdated; check the quote time before use. · 2026-11-02 19:54

Recent news

  • Rating change
    Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/2/28
  • Rating change
    Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $54
    Market Newswire · 2026/3/18
  • Rating change
    Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2026/1/9
  • Rating change
    Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $53
    Market Newswire · 2026/8/4
  • Rating change
    Barclays Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $43
    Market Newswire · 2026/8/5
  • Rating change
    H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/8/4
  • Rating change
    Morgan Stanley Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2025/12/3
  • Company notice
    Indivior: Indivior Pharmaceuticals, Inc. - Cash Distribution and Name/Symbol Change Option Symbol: INDV New Symbol: SUPN
    OCC · 2026/11/3
  • Rating change
    H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $48
    Market Newswire · 2026/1/14
  • Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating
    Market Newswire · 2026/9/18
  • Rating change
    Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $59
    Market Newswire · 2026/5/22
  • Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Posts Q3 Adjusted EPS $1.32 per Share, Vs. FactSet Est of $1.06
    MT Newswires · 2026/10/29
  • Company notice
    Indivior: Indivior Pharmaceuticals, Inc. - Anticipated Cash Distribution Option Symbol: INDV
    OCC · 2026/10/10
  • News On Indivior Pharmaceuticals Inc. (INDV) Now Under SUPN
    Dow Jones · 2026/11/4
  • GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B to $1.37B, Vs. FactSet Est of $1.33B
    MT Newswires · 2026/10/29
  • Rating change
    Barclays Initiates Indivior(INDV.US) With Buy Rating, Announces Target Price $46
    Market Newswire · 2026/6/18
  • Barclays Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/10/28
  • Rating change
    Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2025/12/4
  • Rating change
    Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/1/20
  • Rating change
    Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2025/12/19
  • Rating change
    Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $41
    Market Newswire · 2025/10/31
  • Rating change
    H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2025/10/31
  • Rating change
    Jefferies Initiates Indivior(INDV.US) With Buy Rating, Announces Target Price $20
    Market Newswire · 2025/7/22
  • Rating change
    Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $22
    Market Newswire · 2025/7/1
  • Rating change
    Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $22
    Market Newswire · 2025/7/1

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-02 19:54:59 · For reference only, not investment advice and not tailored to your situation.

Indivior discussion 0 comments

Add a comment